DK38889D0 - Onkogen-indkodet polypeptid med vaekstfaktoraktivitet - Google Patents

Onkogen-indkodet polypeptid med vaekstfaktoraktivitet

Info

Publication number
DK38889D0
DK38889D0 DK038889A DK38889A DK38889D0 DK 38889 D0 DK38889 D0 DK 38889D0 DK 038889 A DK038889 A DK 038889A DK 38889 A DK38889 A DK 38889A DK 38889 D0 DK38889 D0 DK 38889D0
Authority
DK
Denmark
Prior art keywords
growth factor
polypeptide
factor activity
oncogen
encoded polypeptide
Prior art date
Application number
DK038889A
Other languages
English (en)
Other versions
DK175211B1 (da
DK38889A (da
Inventor
Mitchell Goldfarb
Xi Zhan
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of DK38889A publication Critical patent/DK38889A/da
Publication of DK38889D0 publication Critical patent/DK38889D0/da
Application granted granted Critical
Publication of DK175211B1 publication Critical patent/DK175211B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198900388A 1987-05-29 1989-01-27 Onkogen-indkodet polypeptid med vækstfaktoraktivitet, nucleinsyremolekyle kodende herfor, vektor indeholdende nucleinsyremolekylet, værtscellesystem indeholdende vektoren, fremgangsmåde til fremstilling af polypeptidet, præparat indeholdende...... DK175211B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/056,137 US5155217A (en) 1987-05-29 1987-05-29 Ongogene encoding polypeptide having growth factor activity
US5613787 1987-05-29
US8801767 1988-05-26
PCT/US1988/001767 WO1988009378A2 (en) 1987-05-29 1988-05-26 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof

Publications (3)

Publication Number Publication Date
DK38889A DK38889A (da) 1989-01-27
DK38889D0 true DK38889D0 (da) 1989-01-27
DK175211B1 DK175211B1 (da) 2004-07-12

Family

ID=22002413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900388A DK175211B1 (da) 1987-05-29 1989-01-27 Onkogen-indkodet polypeptid med vækstfaktoraktivitet, nucleinsyremolekyle kodende herfor, vektor indeholdende nucleinsyremolekylet, værtscellesystem indeholdende vektoren, fremgangsmåde til fremstilling af polypeptidet, præparat indeholdende......

Country Status (9)

Country Link
US (1) US5155217A (da)
EP (1) EP0317627B1 (da)
JP (1) JP2888846B2 (da)
AT (1) ATE127478T1 (da)
AU (1) AU626268B2 (da)
CA (1) CA1340374C (da)
DE (1) DE3854420T2 (da)
DK (1) DK175211B1 (da)
WO (1) WO1988009378A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238673B2 (en) 1989-03-31 2007-07-03 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
JP2784272B2 (ja) * 1990-06-06 1998-08-06 大正製薬株式会社 腫瘍細胞増殖阻害因子
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US6331523B1 (en) 1998-03-12 2001-12-18 Genentech, Inc. Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5
US6440934B1 (en) 1998-10-13 2002-08-27 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
JP2002527401A (ja) * 1998-10-13 2002-08-27 カイロン コーポレイション Ｆｇｆの脈管形成的に有効な単位用量および投与方法
US20020072489A1 (en) * 1998-10-13 2002-06-13 Whitehouse Martha J. Angiogenically effective unit dose of FGF-2 and method of use
US8618052B2 (en) 1998-10-13 2013-12-31 Novartis Vaccines And Diagnostics, Inc. Method of treating coronary artery disease by administering FGF-5
US20030166550A1 (en) * 1999-08-27 2003-09-04 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
EP1207900A2 (en) * 1999-08-13 2002-05-29 Chiron Corporation Dose of an angiogenic factor and method of administering to improve myocardial blood flow
US20060009393A1 (en) * 1999-10-02 2006-01-12 The Government of the U.S.A as represented by the Secretary of the Dept. of Health & Human Services Immunogenic epitopes for fibroblast growth factors 5 (FGF-5)

Also Published As

Publication number Publication date
JP2888846B2 (ja) 1999-05-10
EP0317627A1 (en) 1989-05-31
CA1340374C (en) 1999-02-02
DE3854420D1 (de) 1995-10-12
AU626268B2 (en) 1992-07-30
AU2262888A (en) 1988-12-21
EP0317627A4 (en) 1990-12-12
DE3854420T2 (de) 1996-05-02
ATE127478T1 (de) 1995-09-15
JPH01503518A (ja) 1989-11-30
DK175211B1 (da) 2004-07-12
WO1988009378A3 (en) 1988-12-15
WO1988009378A2 (en) 1988-12-01
US5155217A (en) 1992-10-13
DK38889A (da) 1989-01-27
EP0317627B1 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
ATE35427T1 (de) Rekombinante dna, damit transformierter mikroorganismus und dessen verwendung.
HUT53125A (en) Process for producing peptides with anticoagulant activity
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.

Legal Events

Date Code Title Description
PUP Patent expired